Benedikt Asey
YOU?
Author Swipe
View article: RMTD-05 PERI-OPERATIVE DEXAMETHASONE USE IN BRAIN METASTASIS SURGERY: ANALYSIS OF PRACTICE VARIATION ACROSS EIGHT NEUROSURGICAL CENTERS
RMTD-05 PERI-OPERATIVE DEXAMETHASONE USE IN BRAIN METASTASIS SURGERY: ANALYSIS OF PRACTICE VARIATION ACROSS EIGHT NEUROSURGICAL CENTERS Open
BACKGROUND Peri-operative corticosteroids are routinely administered in brain metastasis surgery to manage edema, yet standardized dosing protocols are lacking. Practice variation between neurosurgical centers has not been systematically q…
View article: Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis
Altered CD4 T cell response in oligometatastic non-small cell lung cancer brain metastasis Open
Lung cancer is the leading cause of cancer mortality globally, with brain metastasis (BM) in 40% of advanced non-small-cell lung cancer (NSCLC) cases. In 15% of these cases, the brain is the sole affected organ (oligometastasis), which cor…
View article: Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection Open
Importance Variations in perioperative dexamethasone dosing are common in brain metastasis resection, but their impact on patient outcomes remains unclear. Objective To evaluate the association between perioperative dexamethasone dosing an…
View article: Peripheral blood‐derived immune cell counts as prognostic indicators and their relationship with <scp>DNA</scp> methylation subclasses in glioblastoma patients
Peripheral blood‐derived immune cell counts as prognostic indicators and their relationship with <span>DNA</span> methylation subclasses in glioblastoma patients Open
Glioblastomas are known for their immunosuppressive tumor microenvironment, which may explain the failure of most clinical trials in the past decade. Recent studies have emphasized the significance of stratifying glioblastoma patients to p…
View article: RMTD-02 PRACTICE VARIATION AND IMPACT OF PRE-OPERATIVE AND POST-OPERATIVE DEXAMETHASONE ON PATIENT OUTCOME IN THE RESECTED BRAIN METASTASIS – INSIGHTS FROM THE CLINDEXMET MULTICENTER REGISTRY
RMTD-02 PRACTICE VARIATION AND IMPACT OF PRE-OPERATIVE AND POST-OPERATIVE DEXAMETHASONE ON PATIENT OUTCOME IN THE RESECTED BRAIN METASTASIS – INSIGHTS FROM THE CLINDEXMET MULTICENTER REGISTRY Open
BACKGROUND Patients with brain metastases that undergo brain metastasis resection regularly receive perioperative dexamethasone. We sought to evaluate variation in pre- and post-operative dexamethasone dosing and whether perioperative dexa…
View article: NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile
NSCLC patients with oligo-metastatic brain disease show an altered CD4 T-cells immune profile Open
Background Lung cancer is the leading cause of cancer-related deaths worldwide, with brain metastasis (BM) occurring in 40% of advanced non-small cell lung cancer (NSCLC) patients. In 15% of these patients, the brain is the only affected o…
View article: NCOG-01. CLINICAL DETERMINANTS IMPACTING OVERALL SURVIVAL OF PATIENTS WITH OPERABLE BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
NCOG-01. CLINICAL DETERMINANTS IMPACTING OVERALL SURVIVAL OF PATIENTS WITH OPERABLE BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER Open
The incidence of brain metastases (BM) in non-small cell lung cancer (NSCLC) patients is continuously increasing. The recent improvements of systemic treatment in NSCLC necessitate continuous updates on prognostic subgroups and factors det…
View article: Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer Open
Non-small cell lung cancer (NSCLC) is currently the leading cause of cancer-related death worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously increasing. The recent improvements of systemic treatment in …
View article: Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer Open